Sayer Kevin R: insider trades.
Sayer Kevin R reported 5 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($6.4M), across 1 company.
- Transactions
- 5
- Purchases (P)
- 0
- Sales (S)
- 5
- Companies
- 1
- Name as filed
- SAYER KEVIN R
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Dexcom Inc (DXCM) | Director, Officer · Executive Chair | 5 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-20 | Dexcom Inc | S | 19,308 | $89.71 | 309,662 | Form 4 |
| 2026-08-20 | Dexcom Inc | S | 7,351 | $90.78 | 302,311 | Form 4 |
| 2026-08-20 | Dexcom Inc | S | 97 | $91.41 | 302,214 | Form 4 |
| 2026-07-20 | Dexcom Inc | S | 26,756 | $76.32 | 328,970 | Form 4 |
| 2026-07-06 | Dexcom Inc | S | 26,756 | $72 | 355,726 | Form 4 |
Questions
What stock did Sayer Kevin R buy or sell?
Sayer Kevin R reported 5 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($6.4M), across 1 company.
Is Sayer Kevin R the same person as other filers with this name?
This page covers SEC CIK 1286858 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/sayer-kevin-r-1286858.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.